Sangamo Biosciences Inc (SGMO)

[jondoeuk]

Turns out recombinases aren't Profluent's first foray into gene editing. The company made a splash in 2024 when it used AI to make novel CRISPR proteins that don't exist in nature. https://www.nytimes.com/2024/04/22/technology/generative-ai-gene-editing-crispr.html https://www.biorxiv.org/content/10.1101/2024.04.22.590591v1.full

The CEO has insisted that Profluent is not a gene editing company. ''We don't consider ourselves a biotech company, or techbio company,'' he said. ''It's AI-first. That's the identity of the company.'' He also said the start-up's AI models can generate novel proteins broadly.